BDX vs C · P/E 34, rev $21.84B vs P/E 16, rev $85.22B
Becton Dickinson and Company (BDX) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the BDX and C stock pages for the full models.
Not investment advice.